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Introduction
Parkinson’s disease is by no means an uncomplicated
disorder. It is one of the commonest neurological conditions
to affect older people with an overall incidence of 10-20
cases per 1 lakh population per year and a prevalence of
about 160 cases per lakh. It was first described by James
Parkinson, the well known neurologist in his ‘An Essay on
The Shaking Palsy’ in 1871 as “involuntary tremulous motion
with lessened muscular power in the parts not in action and
even when supported with a propensity to bend the trunk
forward, and to pass from a walking to a running pace, the
senses and the intellect being unimpaired.” (Parkinson
1967).
Subsequent studies, have however reported psychiatric
symptoms and organic brain changes associated with the
disorder (Brown et.al. 1990, Aarsland et.al. 1999).
Depression, psychosis and cognitive impairment have been
extensively studied in these patients (Mindham 1970,
Mayeux et.al 1981). Sudden extreme and occasional
unpredictable changes in disability are a characteristic
feature of untreated and treated Parkinson’s disease which
manifest as freezing or paradoxic kinesis. These variables
have been greatly accentuated by the introduction of
levodopa. (Barbeau , 1971).
Mood fluctuations have been reported in up to two thirds
of patients with Parkinson’s disease who experience motor
fluctuations. Most researchers indicate that mood
fluctuations are decreased when the patient is in the ‘on’
(mobile) state and increased when the patient is in the ‘off’
(immobile) state (Richard et.al 2001). Similarly anxiety
(Richard et.al, 1996, Stein et.al. 1990) and obsessive
compulsive symptoms have also been reported. Dementia
is known to affect 40% of the patients with Parkinsonism
and the incidence of dementia in these patients is 6 times
that of the normal population (Emre, 2003).
Though the more apparent effects of parkinsonism are on
the motor system, non motor problems also contribute to
the overall impact of the condition. It is important therefore
that assessment covers the physical, mental and social
domains (Meara, 2001). The disorder has no doubt a
detrimental effect on the quality of life of the patient. The
impact of the disorder may hamper one’s ability to earn a
source of livelihood due to the paralyzing motor disability
with causes and concern for safety due to involuntary
movements and gait problems (Damiano et.al., 1999).
Parkinson’s disease has always been the neurologist’s
domain, but it is essential to study the psychological effects
and the various psychiatric manifestations that may ensue
as a result of the neurological problem.
Aims and Objectives
1. To assess the impact of Parkinson’s disease on
mentation, activities of daily living and motor activity.
2. To study the psychopathology in patients of Parkinson’s
disease having stable and fluctuating symptoms.
3. To assess the level of disability caused by Parkinson’s
disease in both the groups.
4. To compare the quality of life in patients of Parkinson’s
disease having both stable and fluctuating symptoms.
5. To correlate motor symptoms with disease severity,
activities of daily living (ADL), disability, duration of
illness, psychopathology and impact on quality of life of
both the groups.
Material and Method
Sample - The sample consisted of 54 patients of ‘Idiopathic
Parkinson’s Disease’ diagnosed as per criteria of the UK355
Parkinson’s Disease Society Brain Bank (Hughes et.al.,
1992) diagnosed by a Neurologist, and attending the
Movement Disorders Clinic at the Neurology and
Neurosurgery OPD of a general municipal tertiary hospital.
Inclusion Criteria
1. All patients having idiopathic Parkinson’s disease.
2. Patients of all ages, both the sexes and language
compatibility were selected for the study.
3. Patients were screened by the Mini Mental Status
Examination to rule out any cognitive decline.
Exclusion Criteria – Patients having:
1. Parkinson’s disease due to other causes eg. drugs,
arteriosclerosis etc.
2. Cognitive decline and dementia.
3. Any other medical or surgical complications.
4. Language incompatibility.
5. Any sensorimotor difficulty that would impair testing on
scales.
The study was approved by the institutional ethics
committee, and the patients were explained about the nature
of the study and its application and voluntary consent was
obtained from each patient.
Method
All the patients were initially screened by Mini Mental State
Examination (MMSE) (Folstein, et.al., 1975) to rule out
cognitive decline or dementia. The MMSE has a range of
0-30 and only those patients having a score of 19 and above
were considered in the study (Crumm et.al. 1993).  4
patients out of the sample of 54 had a lower score on the
MMSE and so were excluded from the study. All the patients
were examined and assessed on all the scales in the ‘off’
state on the same day.
A proforma was designed in the form of a semi-structured
interview to obtain  information on demographic variables,
disease history and drug therapy.
The clinical examination consisted of :
1. A complete Unified Parkinson’s Disease Rating Scale
(UPDRS) (Fahn & Elton, 1987) assessment that had
the following sections –
◆ Mentation, behaviour and mood (range 0-16 and highest
disease severity indicated by 16),
◆ Activities of daily living (range 0-52 and highest disability
indicated by 52),
◆ Motor section (range 0-56 and highest disease severity
indicated by 56),
◆ The Hoehn and Yahr scale for parkinsonism (range 0-5
and highest disease severity indicated by 5),
◆ The Schwabe and England disability scale (range 0-
100% and the greatest independence indicated by
100%).
Clinical Groups
The scores of the motor section of the UPDRS with the
questions pertaining to tremor, rigidity, bradykinesia, gait,
postural instability, ‘on’ and ‘off’ states, presence or absence
of falls and dyskinesias were taken into account to divide
the patients into two groups –
◆ ◆ ◆ ◆ ◆ Group A – Patients of Parkinson’s disease having
fluctuating symptoms. (N = 34)
◆ ◆ ◆ ◆ ◆ Group B – Patients of Parkinson’s disease having stable
symptoms.   (N = 16)
Psychiatric Assessment
The psychopathology was assessed by the Symptom
Checklist-90 (SCL-90) (Derogatis et.al. 1970) that is
composed of 90 items (each rated on a 5 point lickert type
scale of distress) and 9 primary symptom dimensions
believed to underline the large majority of symptom
behaviours  as under –
I - Somatization.
II - Obsessive Compulsive.
III - Interpersonal Sensitivity.
IV - Depression.
V - Anxiety
VI - Hostility.
VII - Phobic Anxiety.
VIII - Paranoid Ideation.
IX - Psychoticism.
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Quality of Life
The impact of idiopathic parkinsonism on the patient’s
emotional, social and economic status was assessed by the
Parkinson’s Impact Scale (PIMS) (Calne et.al. 1996) across
10 items. Self, feelings, family, community, work, travel,
safety, leisure, financial security and sexuality were the items
assessed. The item was scored from 0-4 with 0 indicating
no change and 4 the most severe.
Data Analysis
The following scores were obtained after administration of
the scales –
1. UPDRS – scores on the mentation, motor activity and
activities of daily living subscales along with a total score.
The Hoehn and Yahr staging along with percentage of
disability was also obtained.
2. PIMS – scores in form of a global(weighted) score
obtained by summation  of all the items.
3. SCL-90 – raw scores on all the symptom dimensions of
the SCL-90 were obtained and the global score of
General  Symptomatic Index (GSI) was calculated as
per the formula.
Statistics
Non parametric tests were chosen because of the ordinal
nature of the scales. Group differences were analysed by
the Mann Whitney U tests (Seigal, S. & Castellan Jr., N.J.,
1988) and the direction and magnitude of the associations
between scale variables with Spearman rank correlation.
Two tailed p values were obtained for all statistical analyses.
Results and Discussion
As shown in Table 1, the sociodemographic profile revealed
the mean age to be 60 ± 9.87 years and 63.12 ± 10.13
years in groups A and B respectively. Males outnumbered
females in both the groups. Nearly 82% of the patients
were married in both the groups, the remaining being
widowed or single. 73% of the patients in Group B had
achieved secondary plus higher education as compared to
55.8% in Group A. There was also a higher frequency of
illiterates in Group A i.e. 23.52%. as compared to Group
B. There are certain studies which have found patient’s
educational status to improve life satisfaction in
Parkinsonism (Cubo et.al 2002). However there were no
significant differences seen in the socio-economic strata
or the employment status of both groups.
Patients with Parkinson’s disease eventually develop a
fluctuating response along with involuntary movements
(dyskinesias) on medication. The scores of the motor section
of UPDRS were considered for dividing the patients into 2
groups (Table 2). A significant difference was noted with
patients in Group A having more rigidity, tremors,
bradykinesia, postural instability, on-off fluctuations and
dyskinesias.
On assessing mentation, behaviour and mood an extremely
significant difference (p < 0.0001) was noted in both the
groups. Patients having fluctuating symptoms experienced
more problems with cognition, periods of sadness, thought
disorder and poor motivation. There are several studies that
report mood fluctuations in patients who are having motor
fluctuations especially in the ‘off’ state. (Richard et.al.,
2001). These minor depressions are more likely to remit
(Mayeux et.al., 1981) and may be closely related to disability
(Starkstein et.al., 1990) which has been corroborated in
our study.
Patients having motor fluctuations begin to lose control of
their daily life as their ability to work or perform their daily
activities may fluctuate with response to medication and
the involuntary movements may interfere with activities
(Adler, 2002). This has also been seen in our study with a
significant difference (p < 0.01) noted on ADL in both the
groups. Patients in Group A reported significant difficulty
in handling their daily routine with respect to eating,
swallowing, hygiene, cutting things, falling etc. Thus patients
having fluctuating symptoms had problems in all areas on
evaluation of the UPDRS (p < 0.001) as compared to those
without motor impairment.
When both the groups were compared for disability on the
Schwabe & England Disability Scale a significant difference
(p < 0.04) was seen (Table 3). This is in keeping with the
results seen in the study (Dural et.al., 2003) where motor
and musculoskeletal impairments correlated with the
disability scores.
The symptomatic profile of all the patients (chart 1) revealed
depressive symptoms to be more marked in both the groups
followed by anxiety and somatization. This is in keeping
with studies by Gottam et.al (1986), Cummings (1992),
Walsch et.al. (2001) and Schiffer et.al. (1988). The
depression in Parkinson’s disease includes a high rate of
anxiety symptoms, little guilt feelings of failure or
punishment and a low suicide rate (Huber et.al. 1990).
Obsessive compulsive symptoms and interpersonal
sensitivity were more marked in Group A than Group B
whereas psychoticism rated the least in both the groups.
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Table  1
AGE AND SEX PROFILE OF BOTH GROUPS
Variable
Grp A Grp B
(N = 34) (N = 16)
Age Mean  Age  (Years) 60 ± 9.87 63.125 ± 10.1
Sex
Males 22 (64.7%) 12 (75%)
Females 12 (35.3%) 4 (25%)
Religion
Hindu 29 (85.29%) 15  (93.75%)
Muslim 5 (12.54%) 1  (6.25%)
Low 16  (47.06%) 5  (31.25%)
S.E.  Status Middle 18  (52.94%) 7  (43.75%)
Upper Middle 0 4  (25%)
Married 28  (82.35%) 13  (81.25%)
Marital Status Single 1  (2.94%) 2  (12.5%)
Widowed 5  (14.7%) 1  (6.25%)
Illiterate 8  (23.52%) 1  (6.25%)
Education Primary 6  (17.64%) 3  (18.75%)
Secondary 15  (44.12%) 9  (56.25%)
Graduate 4  (11.76%) 3  (18.75%)
Retired 19  (55.88%) 8  (50%)
Employment Employed 5  (14.71%) 5  (31.25%)
Unemployed 10  (29.41%) 3  (18.75%)
Table  2
CLINICAL EVALUATION OF PARKINSON’S DISEASE
U.P.D.R.S. Group  A (N = 34) Group  B (N = 16) 2 Tailed
Sectors (Sum of Ranks) (Sum of Ranks) P Value
Motor 985.5 286.5 0.0119*
Mentation & Behaviour 1053.5 221.5 0.0001**
Activities Of Daily Living 990.5 284.5 0.0105*
Total Score 1025 250 0.001**
* Significant   ** Very Significant.
Table 3
DISABILITY IN PATIENTS WITH PARKINSON’S DISEASE
VARIABLE Group  A (N = 34) Group  B (N = 16) 2 Tailed
(Sum of Ranks) (Sum of Ranks) P Value
Schwabe & England
Disability Scale 770 505 0.044*
* significant.
When psychopathology was compared in both the groups
on different dimensions it however revealed a significant
difference on interpersonal sensitivity, phobic anxiety,
psychoticism and depression (Table 4). This could be due
to the fact that patients having motor disability have feelings
of personal inadequacy and inferiority in comparision to
other especially during interpersonal interactions.
Phobic anxiety represents agoraphobia on this measure.
Fear to travel away from home or in public places or
conveyance would therefore seem probable in these patients
having fluctuating symptoms. Phobic disorder, social phobia
and agoraphobia has been identified in patients with
Parkinson’s disease. (Lauterbach, 1991, Stein, et.al., 1990,
Menza et.al., 1993). There have been some studies which
have formed a temporal relationship between the on-off
phenomenon and panic attacks which is also documented
in our study. (Stein et.al. 1990, Menza et.al. 1990, Siemers
et.al. 1993).
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TABLE  4
PSYCHOPATHOLOGY IN PATIENTS  WITH  PARKINSON’S  DISEASE
SCL –90 Group  A (N = 34) Group  B (N = 16) 2 Tailed
DIMENSIONS (Sum of Ranks) (Sum of Ranks) P Value
Somatization 942.5 332.5 0.118
Obsessive Compulsive 954 321 0.07
Inter- Pers Sensitivity 967 308 0.03
Depression 967.5 307.2 0.037*
Anxiety 912 326 0.153
Hostility 951.5 323.5 0.08
Phobic Anxiety 993 282 0.009**
Paranoia 934.5 340 0.163
Psychoticism976.5 298.5 0.02*
Additional 961.5 313.5 0.05
General Symptomatic
Index  (Gsi) 954 321 0.07
* significant.   ** very significant
Psychoticism refers to behaviour viewed as oblique with
items reflecting Schneiderian first rank symptoms. Studies
by Aarsland et.al 1999 and Sanchez-Ramos et.al 1996
reported hallucinations and delusions in patients with
Parkinson’s disease which correlated with levels of akinesia
and rigidity. Similar results were noted in our sample of
patients.
Thus a wide range of neuropsychiatric disturbances were
seen which have also been noted in other studies.
However when the general symptomatic index was
compared for distress no significant difference was noted
in both groups.
Idiopathic Parkinson’s disease being a chronic progressive
neurodegenerative disorder with onset of motor
complications after levodopa therapy for 3-5 years results
in a tremendous impact on QOL, with a reduced health
related QOL when fluctuations are present (Table 5). In
our study all the dimensions of QOL viz. psychological (self,
feelings, leisure and safety), social (community, family,
sexuality), physical activities (work, travel) and economic
dimension (financial security) were significantly affected
in patients with raving motor fluctuations. An item analysis
revealed community relationships (p < 0.006) and travel (p
< 0.003) to be more significantly affected than others. This
could be due to the constraints of motor disability and
dyskinesias that hampered the patient’s mobility and social
interactions. Thus overall QOL suffers in patients having
motor fluctuations. (Adler, 2002 , Schrag, 2000). A higher
economic burden has been studies in patients of motor
fluctuations with a definite increase in healthcare
expenditure (Dodel et.al. 2001) which has also been seen
in our study. The questions on sexuality was optional
because though answered by all did not reveal a significant
difference between the two groups.
As shown in table 6 when the motor UPDRS scores of
both the groups were correlated with different variables
like disease severity (Hoehn and Yahr staging), ADL,
Schwabe and England disability scale, duration of illness,
psychopathology (SCL-90) and impact on QOL (PIMS)
for significance then a defnite correlation was obtained on
ADL (r = 0.6491, p < 0.0001, r = 0.5163 and p < 0.0406)
and PIMS (r = 0.4739 and p < 0.004, r = 0.5239 and p <
0.03) which is in both groups respectively which is in
keeping with several studies (Adler, 2002, Dodel et.al. 2001
and Durel et.al., 2003). However disability (r = -0.62 and p
< 0.0101) and psychopathology (r = 0.5269 and p < 0.036)
could be correlated only in the stable group, thus not
confirming to the hypotheses that patients having motor
fluctuations are at a lower risk of developing
neuropsychiatric disturbances and disability. This could be
due to the fact that though they are having Parkinson’s
disease, they are leading relatively normal lives as  motor
fluctuations have not yet developed. They may therefore
respond to various other stressors as they are not hampered
by motor disability. A study by Aarsland et.al (1999) gave
no correlation between neuropsychiatry symptoms and level
of disability caused by on-off fluctuations and dyskinesias.
The psychopathology in these groups of patients could also
be neurobiologically mediated. The duration of illness or
disease severity however did not have a significant
correlation with motor fluctuations.
Neena S. Sawant et al359
Conclusions
Idiopathic Parkinson’s disease is a chronic progressive
neuropsychiatric disorder affecting people over 60 years
of age. It results in motor complications seen with levodopa
treatment. 68% of patients in our study (n = 34) had motor
fluctuations when these patients were compared with those
who were stable (n=16). For impact of Parkinson’s disease
a significant difference was seen on mentation, behaviour,
mood, ADL and motor disability. Patients having motor
fluctuations also exhibited high levels of interpersonal
sensitivity, phobic anxiety, depression and psychoticism.
Health related QOL was also significant in patients with
motor fluctuations with community relationships and travel
being severely hampered. A distinct correlation of ADL
and QOL with motor symptoms were seen in both groups
whereas psychopathology and level of disability could be
correlated only with the stable patients. This may well mean
that patients with fluctuating symptoms are often the ones
who may be disease oriented mentally and may thus not be
bothered about various social factors and community
participation, while those with stable symptoms try to
Table  5
IMPACT ON THE QUALITY OF LIFE
Parkinson’s Group  A (N = 34) Group  B (N = 16) 2 Tailed
Impact Scale  Items (Sum of Ranks) (Sum of Ranks) P Value
Self  Positive 917 229 0.0014*
Feelings 929 227 0.0004**
Safety 968 307 0.0356*
Leisure 961.5 313.5 0.0498*
Family 979 296 0.0198*
Community 998.5 276.5 0.0061**
Sexuality 902 373 0.4697
Work 978 297 0.0210*
Travel 1007 268 0.0036**
Finance 972.5 302.5 0.0271*
Global (Weighted) Score 1027 248 0.009**
* significant.   ** very significant.
Table – 6
SPEARMAN CORRELATION COEFFICIENT OF MOTOR UPDRS SCORES WITH DISEASE SEVERITY, A.D.L.,
DISABILITY, DURATION OF ILLNESS, PSYCHOPATHOLOGY AND PARKINSON’S IMPACT ON QOL SCALE
Motor Updrs Disease A.D.L. Disability Duration of Psycho- PIMS
Scores Severity Illness Pathology (QOL)
GSI of SCL-90
r rrr rr
Group  A 0.2360 0.6491** - 0. 07840 0.02485 0.1879 0.4739*
Group  B 0.46 0.5163* - 0.62* 0.2896 0.5269* 0.5239*
* Significant  (2 Tailed P Value)
** Extremely  Significant
achieve some kind of social role and community
participation that results in the actual psychopathology and
disability coming to the fore. It is therefore of critical
importance that there is a forward planning to put in place
strategies and services that would effectively address the
needs of this population to maintain their mental well being
and QOL.  A study of this sort would thus be a stepping
stone in this regard.
References
Aarsland, Dag, Larsen, J.P., Lim, N.G., Karlsen, K. & Cummings, J.L.
(1999). The range of neuropsychiatric disturbances in Parkinsonism. Journal
of Neurology, Neurosurgery & Psychiatry, 67, 492-496.
Aarsland, D., Larsen, J.P. & Cummings, J.L. (1999). The prevalence and
clinical correlates of psychosis in Parkinsonism. Archives of Neurology,
56, 595-601.
Adler, C. (2002). Relevance of motor complications in Parkinson’s Disease.
Neurology, 58, (4 Suppl. 1), S51-56.
Barbeau, A. (1971). Long term side effects of levodopa. Lancet, 1, 395.
Brown, R.G. & McCarthy, B. (1990). Psychiatric morbidity among patients
with Parkinson’s Disease. Journal of Psychological Medicine, 20, 77-87.
Behind the Mask : A Study on the Clinical Course360
Calne, S., Schulzer, M., Mak, E. (1996). Validating a quality of life rating
scale for idiopathic parkinsonism : Parkinson’s Impact Scale. Parkinsonism
& Related Disorders, 2, 55-61.
Cole, S.A., Woodard, J.L. & Juneos, J.L. (1996). Depression and disability
in Parkinson’s disease. Journal of Neuropsychiatry, 8, 20-25.
Crumm, R.M., Anthony, J.C., Bassett, S.S. & Folstein, M.F. (1993).
Population based norms for the Mini Mental Status Examination by age
and educational level. Journal of the American Medical Association, 269,
2386-2391.
Cubo, E., Rojo, A., Ramas, S., Quintana, S., Gonzalez, M., Kompoliti, K. &
Aguilar, M. (2002). The importance of educational and psychological
factors in Parkinson’s disease quality of life. European Journal of Neurology,
9 (6), 589.
Cummings, J.L. (1992). Depression and Parkinson’s disease : a review.
American Journal of Psychiatry, 149, 443-454.
Damiano, A.M., Snyder, C., Strausser, B. (1999). A review of Health Related
Quality of Life concepts and measures in Parkinson’s Disease. Quality of
Life Research, 8, 235-243.
Derogatis, L.R., Lipman, R.S., Covi, L. (1970). Dimensions of outpatient
pathology : comparison of a clinical versus an empirical assessment. Journal
of Consulting and Clinical Psychology, 34, 2.
Dodel, R.C., Berger, K. & Oertel, W.H. (2001). Health related quality of
life and health care utilisation in patients with Parkinson’s Disease : impact
of motor fluctuations and dyskinesias. Pharmacoeconomics, 19 (10), 1013-
1038.
Dural, A., Atay, M.B., Akbastanci, C. & Kucukdeveci, A. (2002).
Impairment, disability and life satisfaction in Parkinson’s disease. Disability
and Rehabilitation, 25 (7), 318-323.
Emre, M. (2003). Dementia associated with Parkinson’s disease. Lancet, 2
(4), 229-237.
Fahn, S. & Elton, R.L. (1987). Members of the UPDRS Development
Committee. Unified Parkinson’s Disease Rating Scale. In : Fahn, S., Marsden,
C.D., Calne, D.B. et.al. eds. Recent development in Parkinson’s Disease.
Florham Park, N.J., Macmillan Health Centre Information, 153-163.
Folstein, M.F., Folstein, S.E. & McHugh, P.R. (1975). Mini mental state :
a practical method for grading the mental state of patients for the clinician.
Journal of Psychiatry Research, 12, 189-198.
Gotham, A.M., Brown, R.G. & Marsden, C.D. (1986). Depression in
Parkinson’s disease : a quantitative and qualitative analysis. Journal of
Neurology, Neurosurgery and Psychiatry, 49, 381-389.
Huber, S.J., Freidenberg, D.L., Paulson, G.W., Shuttleworth, A. & Christy,
J.A. (1990). The pattern of depressive symptoms varies with progression
of Parkinson’s Disease. Journal of Neurology, Neurosurgery and Psychiatry,
53, 275-278.
Hughes, A.J., Daniel, S.E., Kilford, L. & Lees, A.J. (1992). Accuracy of
clinical diagnosis of idiopathic Parkinson’s Disease – an analysis of 100
cases. Journal of Neurology, Neurosurgery and Psychiatry, 55, 181-184.
Lauterbach, E.C. & Duvoison, R.C. (1991). Anxiety disorders in familial
parkinsonism (letter). American Journal of Psychiatry, 148, 274.
Mayeux, R., Stern, Y., Rosen, J. & Leventhal, J. (1981). Depression,
intellectual impairment and Parkinson’s disease. Neurology, 31, 645-650.
Mayeux, R., Stern, Y., Williams, J.B., Cote, L., Frantz, A., Dyrenfurth, I.
(1986). Clinical and biochemical features of depression in Parkinson’s
disease. American Journal of Psychiatry, 143, 756-759.
Meara, R.J. (2001). In : Playfer, J.R., Hindle, J.V. (eds). Parkinson’s disease
in the older patient. London, Arnold, pp77-88.
Menza, M.A., Sage, J., Marshall, E., Cody R. & Duvoisin, R. (1990). Mood
changes and the on-off phenomena in Parkinson’s disease. Movement
Disorders, 5, 148-151.
Menza, M.A., Robertson-Hoffman, D.E. & Bonapace, A.S. (1993).
Parkinson’s disease and anxiety : Comorbidity with depression. Biological
Psychiatry, 34, 465-470.
Mindham, R.H.S. (1970). Psychiatric signs and symptoms in Parkinson’s
disease. Journal of Neurology, Neurosurgery and Psychiatry, 33, 188-191.
Parkinson, J. (1871). An Essay on Shaking Palsy. London Sherwood Nelsy
& Jones. Neurology, 17, 427-442.
Richard, I.H., Schiffer, R.B. & Kurlan, R. (1996). Anxiety and Parkinson’s
disease. Journal of Neuropsychiatry & Clinical Neurosciences. 8, 383-392.
Richard, I.H., Justus, A.W. & Kurlan, R. (2001). Relationship between
mood and motor fluctuations in Parkinson’s disease. Journal of
Neuropsychiatry & Clinical Neurosciences, 13, 35-41.
Sanchez-Ramos, J.R., Ortoli, R. & Paulson, G.W. (1996). Visual
hallucinations and Parkinson’s Disease. Archives of Neurology, 56, 595-
601.
Schiffer, R.B., Kurlan, R., Rubin, A. & Boer, S. (1988). Evidence of atypical
depression in Parkinson’s disease. American Journal of Psychiatry, 145,
1020-1022.
Schrag, A., Jahanshahi, M. & Quinn, N. (2000). What contributes to quality
of life in patients with Parkinson’s disease. Journal of Neurology,
Neurosurgery and Psychiatry, 69, 308-312.
Seigal, S. & Castellan, Jr.N.J. (1988). Non parametrical statistics for
behavioural sciences. 2nd edn. MacMillan. Pp 128-137.
Siemers, E.R., Shekhar, A., Quaid, K. & Parker, L. (1993). Anxiety and
motor performance in Parkinson’s disease. Movement Disorders, 8, 501-
506.
Starkstein, S.E., Preziosi, T.J., Bolduc, P.L. & Robinson, R.G. (1990).
Depression in Parkinson’s disease. Journal of Nervous & Mental Disorders,
178, 27-31.
Stein, M.B., Henser, I.J., Juncos, J.L. & Udhe, T.W. (1990). Anxiety disorders
associated with Parkinson’s disease. American Journal of Psychiatry, 147,
217-220.
Walsh, K. & Bennett, G. (2001). Parkinson’s disease and anxiety.
Postgraduate Medical Journal, 77 (904), 89-93.
Neena S. Sawant et al